These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38347789)

  • 1. Uncovering the Mechanisms of Cinnamic Acid Treating Diabetic Nephropathy Based on Network Pharmacology, Molecular Docking, and Experimental Validation.
    Dai L; He Y; Zheng S; Tang J; Fu L; Zhao L
    Curr Comput Aided Drug Des; 2024 Feb; ():. PubMed ID: 38347789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.
    Hu Y; Liu S; Liu W; Zhang Z; Liu Y; Li S; Sun D; Zhang G; Fang J
    Diabetes Metab Syndr Obes; 2022; 15():943-962. PubMed ID: 35378831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
    Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
    J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QiDiTangShen granules alleviates diabetic nephropathy podocyte injury: A network pharmacology study and experimental validation in vivo and vitro.
    Gao F; Zhou Y; Yu B; Xie H; Shi Y; Zhang X; Liu H
    Heliyon; 2024 Jan; 10(1):e23535. PubMed ID: 38223704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking.
    Meng FD; Yuan L; Xu DJ; Che MY; Hou SZ; Lu DD; Liu WJ; Nan Y
    World J Diabetes; 2023 Nov; 14(11):1672-1692. PubMed ID: 38077799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology.
    Yang L; Yuan S; Wang R; Guo X; Xie Y; Wei W; Tang L
    Int Immunopharmacol; 2024 Jan; 126():111237. PubMed ID: 37977063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the mechanism of Dahuang-Tusizi drug pair in the treatment of diabetes nephropathy based on network pharmacology and immune infiltration analysis.
    Liu W; Yuan L; Che M; Hou S; Meng F; Xu D; Nan Y
    Medicine (Baltimore); 2023 Nov; 102(47):e36196. PubMed ID: 38013385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology Combined with Bioinformatics to Investigate the Mechanisms and Molecular Targets of
    Zhao J; Mo C; Shi W; Meng L; Ai J
    Evid Based Complement Alternat Med; 2021; 2021():9980981. PubMed ID: 34349833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating network pharmacology, molecular docking and simulation approaches with machine learning reveals the multi-target pharmacological mechanism of
    Zhang X; Chao P; Zhang L; Lu J; Yang A; Jiang H; Lu C
    J Biomol Struct Dyn; 2024 Feb; ():1-17. PubMed ID: 38379386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.
    Liu MM; Lv NN; Geng R; Hua Z; Ma Y; Huang GC; Cheng J; Xu HY
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):274-289. PubMed ID: 33588742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.
    Bai Z; Xie T; Liu T; Chen Z; Yu L; Zhang C; Luo J; Chen L; Zhao X; Xiao Y
    Front Endocrinol (Lausanne); 2022; 13():967822. PubMed ID: 36213291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
    Li H; Zhu X; Zhang J; Shi J
    Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
    Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
    Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.